Jamjoom Pharmaceuticals Factory Co.
Last Updated:
- 144.00 SAR
- 1.70
- 1.19%
شركة مصنع جمجوم للأدوية
جمجوم فارما
Symbol :
4015
ISIN :
SA15QGU1UNH6
52-Week Range :
134.00
-
183.80
Turnover Ratio :
0.24
Market :
Saudi Exchange
Sector :
Pharma, Biotech & Life Science
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Basic Information
-
Activity :Jamjoom Pharmaceuticals Factory Co. (known as: JAMJOOM PHARMA) is a public company, listed on Saudi Exchange “Tadawul” (TDWL) since June 2023. JAMJOOM PHARMA operats within the pharmaceuticals Research...
-
Industry Group :pharmaceuticals Research and Biotechnology
-
Sub-Industry :
-
ISIN :SA15QGU1UNH6
-
Contact Person :
-
Established On:22-Sep-1994
-
Stock Listing On :20-Jun-2023
-
No of Employees :1,430 Employees as of 2024
-
Outstanding Shares :70,000,000
-
Free Float Shares :
-
Par Value :
-
Paid Capital :
-
Market Cap :
-
Authorized Capital :
Indices Membership
| Action | Date | Index | Provider |
|---|---|---|---|
| Join | 2023 | Pharma, Biotech & Life Science | Saudi Exchange |
| Join | 2023 | Tadawul All Share Index (TASI) | Saudi Exchange |
| Jamjoom Pharmaceuticals Factory Co. |
| Jamjoom Pharma HQ, 6558 Al Ouqsour, 3418, Al-Ruwais, Jeddah 23211, Saudi Arabia |
| T : +966 12 6140099 |
| F : +966 12 6140088 |
| www.jamjoompharma.com |
| IR@Jamjoompharma.com |
Management
| Title | Name | As Of |
|---|---|---|
| Chairman: | Mahmoud Jamjoom | 2022 |
| Vice Chairman: | Ahmed Jamjoom | 2022 |
| Board Member: | Waleed Jamjoom | 2025 |
| Noor Sheriff | 2022 | |
| Mohammed Jamjoom | 2022 | |
| Alaa Jamjoom | 2022 | |
| Faris Al Ghannam | 2022 | |
| Javed Mohammad | 2025 | |
| Benjamin Toogood | 2025 |
Reports
| Date | Title | File |
|---|---|---|
| 2025 | JAMJOOM PHARMA Quarterly Financials Report Q3 2025 | |
| 2025 | Lifera and Jamjoom Pharma Launch Strategic Joint Venture to Power Saudi Arabia’s Biopharma Future | |
| 2025 | Jamjoom Pharma’s net profit surges by 30% YoY to SAR 396 million in 9M 2025 | |
| 2025 | JAMJOOM PHARMA Quarterly Financials Report Q2 2025 | |
| 2025 | Jamjoom Pharma’s net profit surges by 38% YoY to SAR 289 million in 1H 2025 | |
| 2025 | JAMJOOM PHARMA Quarterly Financials Report Q1 2025 | |
| 2025 | Jamjoom Pharma’s net profit surges by 53% YoY to SAR 157 million in 1Q 2025 | |
| 2025 | JAMJOOM PHARMA Annual Financials Report 2024 | |
| 2024 | Jamjoom Pharma reports net profit increase of 22% to SAR 357 million in FY2024 | |
| 2024 | JAMJOOM PHARMA Quarterly Financials Report Q3 2024 | |
| 2024 | Jamjoom Pharma reports SAR 305 million net profit in 9M 2024, up 23% YoY |
